🇺🇸 FDA
Pipeline program

ABI-M201

ABI-M201-101

Phase 1 small_molecule terminated

Quick answer

ABI-M201 for Ulcerative Colitis Chronic Mild is a Phase 1 program (small_molecule) at ASSEMBLY BIOSCIENCES, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
ASSEMBLY BIOSCIENCES, INC.
Indication
Ulcerative Colitis Chronic Mild
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials